Aysun Şengül
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aysun Şengül has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Fulsen Bozkuş
Department of Pulmonology, Faculty of Medicine, Kahramanmaraş Sütçü İmam University, 46000 Kahramanmaraş, Turkey
3 shared publications - Yasemin Söyler
Department of Pulmonology, Atatürk Sanatoryum Training and Research Hospital, 06290 Ankara, Turkey
3 shared publications - Yusuf Aydemir
Department of Pulmonology, Faculty of Medicine, Sakarya University, 54290 Sakarya, Türkiye
3 shared publications - Aylin Çapraz
Department of Pulmonary Medicine, Faculty of Medicine, Amasya University, Amasya 05100, Turkey
2 shared publications - Celal Satici
University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pulmonology, Istanbul, Turkey
2 shared publications - Ersin Alkılınç
Sinop Atatürk State Hospital
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 4 (4) , 111-117
Clinical characteristics and mortality risk factors in COVID-19 patients with pulmonary embolism
Aims: To evaluate the clinical characteristics, radiological findings, and mortality-related factors in patients with COVID-19-associated pulmonary embolism (PE). Methods: This multicenter retrospective cohort study analyzed data from 13 tertiary centers and included adult patients with molecularly confirmed SARS-CoV-2 infection and radiologically verified PE. Results: A total of 112 patients were included (mean age: 59.9±14.1 years), of whom 50% had severe pneumonia. PE and COVID-19 were diagnosed simultaneously in 29.5% of cases. The median interval between COVID-19 diagnosis and PE development was 6 days. Despite standard or intermediate-dose thromboprophylaxis, PE occurred in 42.9% of patients. Computed tomography pulmonary angiography demonstrated predominantly peripheral embolic involvement (58.0%). According to early mortality risk stratification, 5.4% of patients were classified as high risk and 19.6% as intermediate-high risk. The in-hospital and 30-day mortality rates were 7.1% and 12.5%, respectively. Mortality was significantly associated with advanced age, comorbidities, severe pneumonia, thrombocytopenia, elevated lactate dehydrogenase and ferritin levels, high/intermediate-high risk classification, intensive care unit admission, and invasive mechanical ventilation. Multivariate logistic regression identified thrombocytopenia as an independent predictor of 30-day mortality (OR 10.11, 95% CI 1.49-68.92; p=0.01). Conclusion: PE commonly develops during the early phase of COVID-19 and may occur despite thromboprophylaxis. Early recognition and individualized, risk-adapted anticoagulation strategies are essential.
- 28 October 2026
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 4 (4) , 111-117
Open AccessClinical characteristics and mortality risk factors in COVID-19 patients with pulmonary embolism
Aims: To evaluate the clinical characteristics, radiological findings, and mortality-related factors in patients with COVID-19-associated pulmonary embolism (PE). Methods: This multicenter retrospective cohort study analyzed data from 13 tertiary centers and included adult patients with molecularly confirmed SARS-CoV-2 infection and radiologically verified PE. Results: A total of 112 patients were included (mean age: 59.9±14.1 years), of whom 50% had severe pneumonia. PE and COVID-19 were diagnosed simultaneously in 29.5% of cases. The median interval between COVID-19 diagnosis and PE development was 6 days. Despite standard or intermediate-dose thromboprophylaxis, PE occurred in 42.9% of patients. Computed tomography pulmonary angiography demonstrated predominantly peripheral embolic involvement (58.0%). According to early mortality risk stratification, 5.4% of patients were classified as high risk and 19.6% as intermediate-high risk. The in-hospital and 30-day mortality rates were 7.1% and 12.5%, respectively. Mortality was significantly associated with advanced age, comorbidities, severe pneumonia, thrombocytopenia, elevated lactate dehydrogenase and ferritin levels, high/intermediate-high risk classification, intensive care unit admission, and invasive mechanical ventilation. Multivariate logistic regression identified thrombocytopenia as an independent predictor of 30-day mortality (OR 10.11, 95% CI 1.49-68.92; p=0.01). Conclusion: PE commonly develops during the early phase of COVID-19 and may occur despite thromboprophylaxis. Early recognition and individualized, risk-adapted anticoagulation strategies are essential.
- Open Access
- 2 July 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (13) , 2082
Associations of Systemic Immune-Inflammation Index and Hematological Markers with Symptom Burden and Radiological Stage in Sarcoidosis
Background/Objectives: Sarcoidosis is a multisystem inflammatory disease characterized by heterogeneous clinical manifestations and variable disease severity. Hematological inflammatory markers, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), red cell distribution width (RDW), and systemic immune-inflammation index (SII), have recently attracted attention as accessible indicators of systemic inflammation in sarcoidosis. This study aimed to evaluate radiological stage, symptom burden, pulmonary function parameters, and hematological markers in patients with sarcoidosis. Methods: This retrospective multicenter cohort study included histopathologically confirmed sarcoidosis patients from 10 centers. Demographic characteristics, clinical manifestations, pulmonary function test parameters, serum angiotensin-converting enzyme (ACE) levels, and hematological inflammatory markers (MPV, RDW, NLR, PLR, SII) were evaluated. Patients were categorized according to radiological stage (stage 0–I vs. stage II–IV), symptomatic status, and symptom burden (<3 vs. ≥3 symptoms). Results: Among 458 patients included in the study, stage I (47.8%) and stage II (46.9%) disease were the predominant radiological presentations. Patients with stage II–IV disease were older and demonstrated significantly lower forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and diffusing capacity for carbon monoxide (DLCO) values together with higher serum ACE levels compared with stage 0–I disease. Dyspnea, weight loss, and extrapulmonary involvement were more frequent in stage 2–4 disease. No significant associations were observed between radiological stage and NLR, PLR, or SII values. MPV and RDW values differed significantly between symptomatic and asymptomatic patients. Patients with ≥3 symptoms demonstrated significantly lower pulmonary function parameters together with statistically significant higher NLR, PLR, and SII values. In multivariate analyses, only the SII demonstrated an independent association with a high symptom burden. Conclusions: Serum ACE levels were associated with advanced radiological stage, whereas hemogram-derived inflammatory indices, particularly the NLR, PLR, and SII, were associated with symptom burden rather than radiological stage in sarcoidosis and may reflect symptomatic inflammatory activity.
- 2 July 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (13) , 2082
Open AccessAssociations of Systemic Immune-Inflammation Index and Hematological Markers with Symptom Burden and Radiological Stage in Sarcoidosis
Background/Objectives: Sarcoidosis is a multisystem inflammatory disease characterized by heterogeneous clinical manifestations and variable disease severity. Hematological inflammatory markers, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), red cell distribution width (RDW), and systemic immune-inflammation index (SII), have recently attracted attention as accessible indicators of systemic inflammation in sarcoidosis. This study aimed to evaluate radiological stage, symptom burden, pulmonary function parameters, and hematological markers in patients with sarcoidosis. Methods: This retrospective multicenter cohort study included histopathologically confirmed sarcoidosis patients from 10 centers. Demographic characteristics, clinical manifestations, pulmonary function test parameters, serum angiotensin-converting enzyme (ACE) levels, and hematological inflammatory markers (MPV, RDW, NLR, PLR, SII) were evaluated. Patients were categorized according to radiological stage (stage 0–I vs. stage II–IV), symptomatic status, and symptom burden (<3 vs. ≥3 symptoms). Results: Among 458 patients included in the study, stage I (47.8%) and stage II (46.9%) disease were the predominant radiological presentations. Patients with stage II–IV disease were older and demonstrated significantly lower forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and diffusing capacity for carbon monoxide (DLCO) values together with higher serum ACE levels compared with stage 0–I disease. Dyspnea, weight loss, and extrapulmonary involvement were more frequent in stage 2–4 disease. No significant associations were observed between radiological stage and NLR, PLR, or SII values. MPV and RDW values differed significantly between symptomatic and asymptomatic patients. Patients with ≥3 symptoms demonstrated significantly lower pulmonary function parameters together with statistically significant higher NLR, PLR, and SII values. In multivariate analyses, only the SII demonstrated an independent association with a high symptom burden. Conclusions: Serum ACE levels were associated with advanced radiological stage, whereas hemogram-derived inflammatory indices, particularly the NLR, PLR, and SII, were associated with symptom burden rather than radiological stage in sarcoidosis and may reflect symptomatic inflammatory activity.
- Open Access
- 13 April 2023
- Published by Academician Publishing
Konvansiyonel Akciğer Radyolojisi
Bu kitap, konvansiyonel akciğer radyolojisi hakkında temel bilgileri sunmayı amaçlayan bir kaynaktır. Akciğer hastalıklarının tanısında kullanılan konvansiyonel akciğer grafisi, diğer görüntüleme yöntemlerine göre daha kolay ulaşılabilir, daha az radyasyon içeren ve daha ekonomik bir seçenektir. Kitap, akciğer grafisi çekim tekniklerini, normal akciğer anatomisini ve patolojik radyolojik bulguları anlatmaktadır. Ayrıca, örnek olgu sunumlarıyla konuların daha iyi anlaşılmasını sağlamaktadır. Bu kitap, akciğer grafisi değerlendirmesinde bilgisini arttırmak isteyen tüm sağlık profesyonellerine faydalı olmayı hedeflemektedir. This book is a source that aims to provide basic information about conventional lung radiology. Conventional lung radiography, which is used in the diagnosis of lung diseases, is a more accessible, less radiation-exposing, and more economical option compared to other imaging methods. The book explains lung radiography techniques, normal lung anatomy, and pathological radiological findings. Additionally, it facilitates better understanding of the topics through sample case presentations. This book aims to be beneficial to all healthcare professionals who want to increase their knowledge in lung radiography evaluation.
- 13 April 2023
- Published by Academician Publishing
Open AccessKonvansiyonel Akciğer Radyolojisi
Bu kitap, konvansiyonel akciğer radyolojisi hakkında temel bilgileri sunmayı amaçlayan bir kaynaktır. Akciğer hastalıklarının tanısında kullanılan konvansiyonel akciğer grafisi, diğer görüntüleme yöntemlerine göre daha kolay ulaşılabilir, daha az radyasyon içeren ve daha ekonomik bir seçenektir. Kitap, akciğer grafisi çekim tekniklerini, normal akciğer anatomisini ve patolojik radyolojik bulguları anlatmaktadır. Ayrıca, örnek olgu sunumlarıyla konuların daha iyi anlaşılmasını sağlamaktadır. Bu kitap, akciğer grafisi değerlendirmesinde bilgisini arttırmak isteyen tüm sağlık profesyonellerine faydalı olmayı hedeflemektedir. This book is a source that aims to provide basic information about conventional lung radiology. Conventional lung radiography, which is used in the diagnosis of lung diseases, is a more accessible, less radiation-exposing, and more economical option compared to other imaging methods. The book explains lung radiography techniques, normal lung anatomy, and pathological radiological findings. Additionally, it facilitates better understanding of the topics through sample case presentations. This book aims to be beneficial to all healthcare professionals who want to increase their knowledge in lung radiography evaluation.
- Open Access
- 26 January 2023
- Published by Academician Publishing
Granülomatöz Akciğer Hastalıkları
Granülomatöz akciğer hastalıkları, çeşitli klinik belirtilere ve sonuçlara sahip olan heterojen bir hastalık grubudur. Bu hastalıkların teşhisi genellikle zordur ve enfeksiyöz (mikobakteriler ve mantarlar) ve enfeksiyöz olmayan akciğer hastalıklarını içerir. Tanı için klinik değerlendirme, laboratuvar testleri, solunum fonksiyon testi, radyolojik görüntüleme ve histopatolojik değerlendirme gibi yöntemler kullanılır. Granülom, nonspesifik bir histopatolojik bulgu olduğundan, kesin tanı için ek testler gerekebilir. Bu kitap, granülomatöz akciğer hastalıklarının tanı ve tedavi yaklaşımları hakkında bilgi sunmayı amaçlamaktadır. Granulomatous lung diseases are a heterogeneous group of diseases with various clinical symptoms and outcomes. The diagnosis of these diseases is often challenging and includes both infectious (mycobacteria and fungi) and non-infectious lung diseases. Methods such as clinical evaluation, laboratory tests, pulmonary function testing, radiological imaging, and histopathological evaluation are used for diagnosis. Since granuloma is a non-specific histopathological finding, additional tests may be required for a definitive diagnosis. This book aims to provide information on the diagnosis and treatment approaches of granulomatous lung diseases.
- 26 January 2023
- Published by Academician Publishing
Open AccessGranülomatöz Akciğer Hastalıkları
Granülomatöz akciğer hastalıkları, çeşitli klinik belirtilere ve sonuçlara sahip olan heterojen bir hastalık grubudur. Bu hastalıkların teşhisi genellikle zordur ve enfeksiyöz (mikobakteriler ve mantarlar) ve enfeksiyöz olmayan akciğer hastalıklarını içerir. Tanı için klinik değerlendirme, laboratuvar testleri, solunum fonksiyon testi, radyolojik görüntüleme ve histopatolojik değerlendirme gibi yöntemler kullanılır. Granülom, nonspesifik bir histopatolojik bulgu olduğundan, kesin tanı için ek testler gerekebilir. Bu kitap, granülomatöz akciğer hastalıklarının tanı ve tedavi yaklaşımları hakkında bilgi sunmayı amaçlamaktadır. Granulomatous lung diseases are a heterogeneous group of diseases with various clinical symptoms and outcomes. The diagnosis of these diseases is often challenging and includes both infectious (mycobacteria and fungi) and non-infectious lung diseases. Methods such as clinical evaluation, laboratory tests, pulmonary function testing, radiological imaging, and histopathological evaluation are used for diagnosis. Since granuloma is a non-specific histopathological finding, additional tests may be required for a definitive diagnosis. This book aims to provide information on the diagnosis and treatment approaches of granulomatous lung diseases.
- Open Access
EVALUATION OF PATIENTS WITH COVID-19 RECEIVING LONG-TERM OXYGEN SUPPORT IN POST-COVID PERIOD
- Open Access
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1012-1020
The relationship of extent of initial radiological involvement with the need of intensive care, mortality rates, and laboratory parameters in Covid-19
It is very important for the efficient use of limited capacity and the success of treatment to predict patients who may need ICU with high mortality rate in the Covid 19 outbreak. In our study; it was aimed to investigate the value of the radiological involvement on initial CT in demonstrating the ICU transfer and mortality rate of patients Method: All PCR positive patients were included in the study, whose CT, PCR, and laboratory values were obtained simultaneously at the time of first admission. Patients were divided into 4 groups in terms of the extent of radiological lesions. These groups were compared in terms of Intensive care transfer needs and covid-related mortality rates. A total of 477 patients were included in the study. 90 of them were group 0 (no lung involvement), 162 were group 1 (mild lesion), 89 were group 2 (moderate lesion) and 136 were group 3 (severe lung involvement). A significant relationship was found between the extensiveness of the radiological lesion on CT and admission to intensive care and mortality rate. As the initial radiological involvement amounts increased, the rate of ICU transfer and mortality increased. The mortality rates of the groups were 0%, 3%, 12.3%, 12.5%, respectively, and the difference was significant (p<0.001). Similarly; the ICU transfer rates of the groups were 2.2%, 5.6%, 13.5% and 17.7%, respectively, and the difference was significant (p<0.001). In conclusion, in our study, the strong relationship between the initial radiological extent assessment and the need for intensive care and mortality rates has been demonstrated , and we believe that our results will make a significant contribution to increase the success of the health system in predicting patients who may progress, helping clinicians and managing pandemics.
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1012-1020
Open AccessThe relationship of extent of initial radiological involvement with the need of intensive care, mortality rates, and laboratory parameters in Covid-19
It is very important for the efficient use of limited capacity and the success of treatment to predict patients who may need ICU with high mortality rate in the Covid 19 outbreak. In our study; it was aimed to investigate the value of the radiological involvement on initial CT in demonstrating the ICU transfer and mortality rate of patients Method: All PCR positive patients were included in the study, whose CT, PCR, and laboratory values were obtained simultaneously at the time of first admission. Patients were divided into 4 groups in terms of the extent of radiological lesions. These groups were compared in terms of Intensive care transfer needs and covid-related mortality rates. A total of 477 patients were included in the study. 90 of them were group 0 (no lung involvement), 162 were group 1 (mild lesion), 89 were group 2 (moderate lesion) and 136 were group 3 (severe lung involvement). A significant relationship was found between the extensiveness of the radiological lesion on CT and admission to intensive care and mortality rate. As the initial radiological involvement amounts increased, the rate of ICU transfer and mortality increased. The mortality rates of the groups were 0%, 3%, 12.3%, 12.5%, respectively, and the difference was significant (p<0.001). Similarly; the ICU transfer rates of the groups were 2.2%, 5.6%, 13.5% and 17.7%, respectively, and the difference was significant (p<0.001). In conclusion, in our study, the strong relationship between the initial radiological extent assessment and the need for intensive care and mortality rates has been demonstrated , and we believe that our results will make a significant contribution to increase the success of the health system in predicting patients who may progress, helping clinicians and managing pandemics.
- 27 March 2021
- Published by Academician Publishing
- p. 355-366
Hiperkoagülabilite, Antikoagülan Tedaviler ve Covid-19
- 27 March 2021
- Published by Academician Publishing
- p. 355-366
Hiperkoagülabilite, Antikoagülan Tedaviler ve Covid-19
- Open Access
- 1 January 2019
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 70 (1) , 42-47
The relationship between serum bicarbonate, pH level and sleep quality in hemodialysis patients: A cross-sectional study from Turkey
To investigate the relationship of blood pH and bicarbonate levels with sleep disorders in patients with end-stage renal disease. The cross-sectional study was conducted at Kocaeli Derince Health Practice and Research Center, Kocaeli, Turkey, in July 2015, and comprised stable haemodialysis patients aged over 18 years who had undergone at least 3 months of treatment. The Pittsburgh sleep quality index was used to assess sleep quality, and the Epworth sleepiness scale was used to assess sleepiness. Blood urea nitrogen levels were measured to determine dialysis success. SPSS 17 was used for data analysis. Of the 62 patients, 22(35.4%) were good sleepers, while 40(65.6%) were bad sleepers, and 11(17.7%) had excessive daytime sleepiness. There was no significant difference between poor and good sleepers with respect to venous pH (p=0.197) and bicarbonate (p=0.305) levels. Also, the two levels did not differ significantly between patients with routine or excessive daytime sleepiness (p>0.05). Patients with excessive daytime sleepiness had significantly lower calcium (p=0.046) and higher creatinine (p-0.014) levels and were older (p=0.01). Age was the only independent predictor of both the index and the scale scores (p<0.05 each). Sleep disorders and sleepiness were found to be high in haemodialysis patients and there was a strong correlation between sleep disturbance and age. There was no correlation of either state with patients' bicarbonate or venous pH values.
- 1 January 2019
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 70 (1) , 42-47
Open AccessThe relationship between serum bicarbonate, pH level and sleep quality in hemodialysis patients: A cross-sectional study from Turkey
To investigate the relationship of blood pH and bicarbonate levels with sleep disorders in patients with end-stage renal disease. The cross-sectional study was conducted at Kocaeli Derince Health Practice and Research Center, Kocaeli, Turkey, in July 2015, and comprised stable haemodialysis patients aged over 18 years who had undergone at least 3 months of treatment. The Pittsburgh sleep quality index was used to assess sleep quality, and the Epworth sleepiness scale was used to assess sleepiness. Blood urea nitrogen levels were measured to determine dialysis success. SPSS 17 was used for data analysis. Of the 62 patients, 22(35.4%) were good sleepers, while 40(65.6%) were bad sleepers, and 11(17.7%) had excessive daytime sleepiness. There was no significant difference between poor and good sleepers with respect to venous pH (p=0.197) and bicarbonate (p=0.305) levels. Also, the two levels did not differ significantly between patients with routine or excessive daytime sleepiness (p>0.05). Patients with excessive daytime sleepiness had significantly lower calcium (p=0.046) and higher creatinine (p-0.014) levels and were older (p=0.01). Age was the only independent predictor of both the index and the scale scores (p<0.05 each). Sleep disorders and sleepiness were found to be high in haemodialysis patients and there was a strong correlation between sleep disturbance and age. There was no correlation of either state with patients' bicarbonate or venous pH values.
- 1 September 2015
- Published by European Respiratory Society (ERS)
- Vol. 46 (suppl 59) , PA3576
Evaluation of antiinflammatory and antioxidant effect of mepenzolate in subacute cigarette exposure mouse model
Aim: Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease mainly caused by tobacco smoke inhalation. We aimed to evaluate antiinflamatory and antioxidant effect of mepenzolate bromide which is a muscarinic antagonist in subacute cigarette exposure mice model. Method: Forty seven healthy 25-40 gram male mices were categorized into 4 groups: (A) control group (n=7), (B) exposed to cigarette smoke (CS) (n=18), and (C) exposed to CS treated with 400 mikrogram/kg/ day mepenzolate group(n=14),( D) treated with 400 mikrogram/kg/ day mepenzolate group (n=8). After 5 weeks, mepenzolate or saline was given to mices during two weeks by inhalation. Mices were anesthetized, broncoalveolar lavage (BAL) was performed, lung tissues was removed. Interleukin-1β (IL1β), macrophage inflammatory protein-1 (MIP 1), tumor necrosis factor alpha (TNF α) measurements were evaluated in BAL fluid and total oxidant and antioxsidant status (TAS-TOS) were measured in lung tissues. Results: We found that cigarettes exposure significantly decreased TAS and increased TOS (pConclusions: Mepenzolate may be a promising therapeutic choice to reduce oxidative effect and to control inflammation due to cigarette exposure.
- 1 September 2015
- Published by European Respiratory Society (ERS)
- Vol. 46 (suppl 59) , PA3576
Evaluation of antiinflammatory and antioxidant effect of mepenzolate in subacute cigarette exposure mouse model
Aim: Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease mainly caused by tobacco smoke inhalation. We aimed to evaluate antiinflamatory and antioxidant effect of mepenzolate bromide which is a muscarinic antagonist in subacute cigarette exposure mice model. Method: Forty seven healthy 25-40 gram male mices were categorized into 4 groups: (A) control group (n=7), (B) exposed to cigarette smoke (CS) (n=18), and (C) exposed to CS treated with 400 mikrogram/kg/ day mepenzolate group(n=14),( D) treated with 400 mikrogram/kg/ day mepenzolate group (n=8). After 5 weeks, mepenzolate or saline was given to mices during two weeks by inhalation. Mices were anesthetized, broncoalveolar lavage (BAL) was performed, lung tissues was removed. Interleukin-1β (IL1β), macrophage inflammatory protein-1 (MIP 1), tumor necrosis factor alpha (TNF α) measurements were evaluated in BAL fluid and total oxidant and antioxsidant status (TAS-TOS) were measured in lung tissues. Results: We found that cigarettes exposure significantly decreased TAS and increased TOS (pConclusions: Mepenzolate may be a promising therapeutic choice to reduce oxidative effect and to control inflammation due to cigarette exposure.